Neuropeptide EI, rat displays functional melanin concentrating hormone (MCH)-antagonist and melanocyte-stimulating hormone (MSH) agonist activity in different behavioral paradigms.
Neuropeptide EI, rat is a naturally occurring peptide isolated from rat tissues, recognized for its role as a member of the neuropeptide family involved in neuronal signaling and regulatory processes within the central nervous system. As a biologically active peptide, it contributes to the intricate network of chemical messengers that modulate synaptic transmission, neuroendocrine function, and various physiological responses. Owing to its unique sequence and functional profile, Neuropeptide EI has become a valuable research tool for elucidating the molecular mechanisms underlying neuronal communication, peptide receptor interactions, and the broader landscape of peptide-mediated signaling pathways.
Neuropharmacology research: Neuropeptide EI serves as a critical probe for investigating the neurochemical mechanisms that govern synaptic activity and neurotransmitter release. By applying this peptide in in vitro and ex vivo models, researchers can dissect its influence on neuronal excitability, receptor modulation, and downstream signaling cascades. Such studies provide foundational insights into the functional diversity of neuropeptides and their roles in shaping neural circuit dynamics, supporting the discovery of new molecular targets within the nervous system.
Receptor characterization: The peptide is frequently utilized in receptor-binding assays and ligand-receptor interaction studies to identify and characterize its cognate receptors or binding partners. By employing radiolabeled or fluorescently tagged forms of Neuropeptide EI, scientists can map receptor distribution, determine binding affinities, and evaluate receptor specificity across various brain regions or neuronal populations. These applications are instrumental in advancing the understanding of peptide-receptor networks and their physiological significance.
Peptide signaling pathway analysis: Neuropeptide EI is employed to activate or modulate specific intracellular signaling pathways in cell-based assays and organotypic cultures. Through controlled administration, investigators can monitor the downstream effects on second messenger systems, kinase activation, or gene expression profiles. Such experiments are crucial for unraveling the molecular underpinnings of peptide-driven signaling events and for delineating the cross-talk between neuropeptide systems and other modulatory pathways.
Functional neuroanatomy studies: The peptide is used as a molecular tool in tracing experiments and functional mapping of neural circuits. By microinjecting Neuropeptide EI into targeted brain regions or neural networks, researchers can assess its impact on neuronal firing patterns, synaptic plasticity, and behavioral correlates in animal models. These approaches facilitate a deeper comprehension of the spatial and functional organization of neuropeptide pathways within the central nervous system.
Peptide structure-activity relationship (SAR) studies: Synthetic analogs and sequence variants of Neuropeptide EI are often synthesized and evaluated to determine the structural features critical for biological activity. By systematically modifying specific residues or functional groups, researchers can elucidate the determinants of receptor binding, potency, and selectivity. These SAR investigations provide valuable information for the design of novel peptide-based probes, modulators, or research reagents tailored to specific experimental objectives.
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.